Safety and efficacy of fecal microbiota transplantation (FMT) in the management of recurrent clostridioides difficile infection (rCDI) in cancer patients.

被引:0
|
作者
Ali, Hiba
Ma, Weijie
Khurana, Shruti
Jiang, Zhi-Dong
DuPont, Herbert L.
Okhuysen, Pablo
Thomas, Anusha
Wang, Yinghong
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[4] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA
[5] Kelsey Res Fdn, Houston, TX USA
[6] UT MD Anderson Canc Ctr, Houston, TX USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e24048
引用
收藏
页数:2
相关论文
共 50 条
  • [1] The Role of Loperamide in Conjunction With Fecal Microbiota Transplantation (FMT) for Recurrent Clostridioides difficile Infection (rCDI)
    Nayi, Vipul
    Brandt, Lawrence
    Aroniadis, Olga
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S97 - S98
  • [2] REPORTING OF RANDOMIZED CONTROLLED TRIAL METHODOLOGICAL CHARACTERISTICS OF FECAL MICROBIOTA TRANSPLANTATION (FMT) FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION (RCDI)
    Khanna, Sahil
    Aroniadis, Olga C.
    Garcia, Mariana
    Svedlund, Felicia L.
    Ong, Kevin
    Stong, Laura
    Boules, Mena
    Feuerstadt, Paul
    GASTROENTEROLOGY, 2020, 158 (06) : S990 - S991
  • [3] Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients
    Ali, Hiba
    Khurana, Shruti
    Ma, Weijie
    Peng, Yuanzun
    Jiang, Zhi-Dong
    DuPont, Herbert
    Zhang, Hao Chi
    Thomas, Anusha S.
    Okhuysen, Pablo
    Wang, Yinghong
    JOURNAL OF CANCER, 2021, 12 (21): : 6498 - 6506
  • [4] Safety and Efficacy of Fecal Microbiota Transplantation (FMT) for Recurrent Clostridium difficile Infection (RCDI) in Septuagenarians, Octogenarians, and Nonegenarians: A Single-Center Experience
    Anand, Rohit
    Girotra, Mohit
    Garg, Shashank
    Dutta, Sudhir
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S195 - S195
  • [5] EFFICACY AND SAFETY OF FECAL MICROBIOTA TRANSPLANTATION IN CANCER PATIENTS WITH RECURRENT CLOSTRIDIUM DIFFICILE INFECTION
    Ali, Hiba
    Khurana, Shruti
    Okhuysen, Pablo C.
    Wang, Yinghong
    GASTROENTEROLOGY, 2020, 158 (06) : S988 - S988
  • [6] Potential Cost Savings Associated With Timely Fecal Microbiota Transplantation (FMT) for Recurrent Clostridium difficile Infection (RCDI)
    Atkins, Kerry A.
    Kao, Dina
    GASTROENTEROLOGY, 2014, 146 (05) : S252 - S252
  • [7] Fecal microbiota transplantation for recurrent Clostridioides difficile infection
    Haber, Stacy L.
    Raney, Carrington R. K.
    Larson, Trent L.
    Lau, Jennifer Park
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (13) : 935 - 942
  • [8] Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
    Fareed, Shaaz
    Sarode, Neha
    Stewart, Frank J.
    Malik, Aneeq
    Laghaie, Elham
    Khizer, Saadia
    Yan, Fengxia
    Pratte, Zoe
    Lewis, Jeffery
    Immergluck, Lilly Cheng
    PEERJ, 2018, 6
  • [9] Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection
    Voth, Elida
    Khanna, Sahil
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (07) : 669 - 676
  • [10] Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection: Efficacy and Predictors of Success
    Abdallah, Mohamed
    Abdalla, Abdelmohaymin
    Wiedel, Noah
    Baloun, Brett
    Gilbert, Jorge
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S78 - S78